Medical Data Vision Co., Ltd.

TSE:3902 Rapport sur les actions

Capitalisation boursière : JP¥18.5b

La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Medical Data Vision Croissance future

Future contrôle des critères 4/6

Medical Data Vision is forecast to grow earnings and revenue by 22.6% and 11.4% per annum respectively. EPS is expected to grow by 22.5% per annum. Return on equity is forecast to be 16.2% in 3 years.

Informations clés

22.6%

Taux de croissance des bénéfices

22.5%

Taux de croissance du BPA

Healthcare Services croissance des bénéfices15.5%
Taux de croissance des recettes11.4%
Rendement futur des capitaux propres16.2%
Couverture par les analystes

Low

Dernière mise à jour15 Aug 2024

Mises à jour récentes de la croissance future

Recent updates

Medical Data Vision (TSE:3902) Has Affirmed Its Dividend Of ¥6.50

Aug 10
Medical Data Vision (TSE:3902) Has Affirmed Its Dividend Of ¥6.50

Medical Data Vision Co., Ltd. (TSE:3902) Stocks Shoot Up 25% But Its P/E Still Looks Reasonable

Jun 25
Medical Data Vision Co., Ltd. (TSE:3902) Stocks Shoot Up 25% But Its P/E Still Looks Reasonable

Why Medical Data Vision Co., Ltd. (TSE:3902) Could Be Worth Watching

Jun 13
Why Medical Data Vision Co., Ltd. (TSE:3902) Could Be Worth Watching

Prévisions de croissance des bénéfices et des revenus

TSE:3902 - Estimations futures des analystes et données financières antérieures (JPY Millions )
DateRecettesLes revenusFlux de trésorerie disponibleCash from OpMoy. Nombre d'analystes
12/31/20268,7909758321,0352
12/31/20257,8907406626752
12/31/20247,0905704424962
6/30/20246,197448103250N/A
3/31/20246,248689N/AN/AN/A
12/31/20236,4199791,5861,616N/A
9/30/20236,264753N/AN/AN/A
6/30/20236,2507931,5171,577N/A
3/31/20236,152832N/AN/AN/A
12/31/20226,104870857910N/A
9/30/20226,0471,164N/AN/AN/A
6/30/20225,8931,125967989N/A
3/31/20225,7541,091N/AN/AN/A
12/31/20215,6721,0871,0581,082N/A
9/30/20215,378872N/AN/AN/A
6/30/20215,1688651,2231,253N/A
3/31/20214,966858N/AN/AN/A
12/31/20204,579700937964N/A
9/30/20204,422770N/AN/AN/A
6/30/20204,286700722738N/A
3/31/20204,199637N/AN/AN/A
12/31/20194,0265541,1211,202N/A
9/30/20193,931522N/AN/AN/A
6/30/20193,891329490607N/A
3/31/20193,743188N/AN/AN/A
12/31/20183,577692120N/A
9/30/20183,519137N/AN/AN/A
6/30/20183,36418260231N/A
3/31/20183,283257N/AN/AN/A
12/31/20173,225354N/A486N/A
9/30/20173,009178N/AN/AN/A
6/30/20172,929272N/A635N/A
12/31/20162,632178N/A196N/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: 3902's forecast earnings growth (22.6% per year) is above the savings rate (0.3%).

Bénéfices vs marché: 3902's earnings (22.6% per year) are forecast to grow faster than the JP market (8.5% per year).

Croissance élevée des bénéfices: Les bénéfices de 3902 devraient augmenter de manière significative au cours des 3 prochaines années.

Chiffre d'affaires vs marché: 3902's revenue (11.4% per year) is forecast to grow faster than the JP market (4.3% per year).

Croissance élevée des revenus: 3902's revenue (11.4% per year) is forecast to grow slower than 20% per year.

Prévisions de croissance du bénéfice par action

Rendement futur des capitaux propres

ROE futur: 3902's Return on Equity is forecast to be low in 3 years time (16.2%).

Découvrir les entreprises en croissance

7D

1Y

7D

1Y

7D

1Y